Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anisha Mathew

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
The Indian Journal of Medical Research|June 6, 2022
Quality of life assessment & out-of-pocket expenditure in multiple myeloma: An observational studyAnisha Mathew, Habib Hasan Farooqui, Lalit Kumar
EJIFCC|February 9, 2026
Case-Based Analysis of Pre-analytical and Analytical Non-Conformities in Urinary Protein TestingSajjad Bakhtiari, Majid Sirati-Sabet, Anisha Mathew, et al.
The Lancet Regional Health. Southeast Asia|March 3, 2025
Corrigendum to "Access to timely cancer treatment initiation in India: extent, determinants and trends" [The Lancet Regional Health - Southeast Asia, Volume 32, January 2025, 100514]Pritam Halder, Jyoti Dixit, Nidhi Gupta, et al.
The Lancet Regional Health. Southeast Asia|January 13, 2025
Access to timely cancer treatment initiation in India: extent, determinants and trendsPritam Halder, Jyoti Dixit, Nidhi Gupta, et al.
The Lancet Regional Health. Southeast Asia|June 29, 2023
Cost-effectiveness analysis of different combination therapies for the treatment of chronic lymphocytic leukaemia in IndiaPrerika Nehra, Akashdeep Singh Chauhan, Pankaj Malhotra, et al.
Applied Health Economics and Health Policy|March 6, 2024
Cost-Effectiveness of Novel Agent Regimens for Transplant-Eligible Newly Diagnosed Multiple Myeloma Patients in IndiaJyoti Dixit, Pankaj Malhotra, Nikita Mehra, et al.
South Asian Journal of Cancer|December 25, 2025
Upfront Combined Hydroxyurea and Imatinib versus Imatinib Monotherapy in Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia: A Randomized Controlled TrialRituparna Chetia, Sarika Palepu, Vikramjeet Dutta, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 22, 2022
Multiple Myeloma: Impact of Time to Transplant on the OutcomeLalit Kumar, Mohammad Mir Hussain, Rajegowda Chethan, et al.
Leukemia & Lymphoma|November 23, 2022
Autologous stem cell transplant for multiple myeloma: Impact of melphalan dose on the transplant outcomeLalit Kumar, Ranjit Kumar Sahoo, Sudhir Kumar, et al.
Applied Health Economics and Health Policy|May 9, 2022
Cost Effectiveness of Ribociclib and Palbociclib in the Second-Line Treatment of Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer in Post-Menopausal Indian WomenNidhi Gupta, Dharna Gupta, Jyoti Dixit, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
The Indian Journal of Medical Research|June 6, 2022
Quality of life assessment & out-of-pocket expenditure in multiple myeloma: An observational studyAnisha Mathew, Habib Hasan Farooqui, Lalit Kumar
EJIFCC|February 9, 2026
Case-Based Analysis of Pre-analytical and Analytical Non-Conformities in Urinary Protein TestingSajjad Bakhtiari, Majid Sirati-Sabet, Anisha Mathew, et al.
The Lancet Regional Health. Southeast Asia|March 3, 2025
Corrigendum to "Access to timely cancer treatment initiation in India: extent, determinants and trends" [The Lancet Regional Health - Southeast Asia, Volume 32, January 2025, 100514]Pritam Halder, Jyoti Dixit, Nidhi Gupta, et al.
The Lancet Regional Health. Southeast Asia|January 13, 2025
Access to timely cancer treatment initiation in India: extent, determinants and trendsPritam Halder, Jyoti Dixit, Nidhi Gupta, et al.
The Lancet Regional Health. Southeast Asia|June 29, 2023
Cost-effectiveness analysis of different combination therapies for the treatment of chronic lymphocytic leukaemia in IndiaPrerika Nehra, Akashdeep Singh Chauhan, Pankaj Malhotra, et al.
Applied Health Economics and Health Policy|March 6, 2024
Cost-Effectiveness of Novel Agent Regimens for Transplant-Eligible Newly Diagnosed Multiple Myeloma Patients in IndiaJyoti Dixit, Pankaj Malhotra, Nikita Mehra, et al.
South Asian Journal of Cancer|December 25, 2025
Upfront Combined Hydroxyurea and Imatinib versus Imatinib Monotherapy in Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia: A Randomized Controlled TrialRituparna Chetia, Sarika Palepu, Vikramjeet Dutta, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 22, 2022
Multiple Myeloma: Impact of Time to Transplant on the OutcomeLalit Kumar, Mohammad Mir Hussain, Rajegowda Chethan, et al.
Leukemia & Lymphoma|November 23, 2022
Autologous stem cell transplant for multiple myeloma: Impact of melphalan dose on the transplant outcomeLalit Kumar, Ranjit Kumar Sahoo, Sudhir Kumar, et al.
Applied Health Economics and Health Policy|May 9, 2022
Cost Effectiveness of Ribociclib and Palbociclib in the Second-Line Treatment of Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer in Post-Menopausal Indian WomenNidhi Gupta, Dharna Gupta, Jyoti Dixit, et al.
Pageof 2